EpiVax Oncology, Inc.

Amendment
CIK: 0001724741·Biotechnology·DELAWARE·Filed: Dec 14, 2018
Total Offering

$2,000,000

Amount Sold

$1,405,000

Investors

14

First Sale

Nov 30, 2017

Offering Details

Type
Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
Anne De Groot
Related Person
William Martin
Related Person
Gad Berdugo
Related Person

Company

EpiVax Therapeutics, Inc.

146 CLIFFORD STREET

PROVIDENCE, RI, 02903

(401)272-2123

SEC Filing

0001724741-18-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
EpiVax Oncology, Inc. Form D Filing — $2,000,000 | FilingFlow